TENS Use for Post-cesarean Pain Management
ConditionPost Cesarean Pain Management
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorHoly Family Hospital, Nazareth, Israel
About this trial
The aim of this randomized controlled trial is to evaluate the effectiveness of continuous 24-hour Transcutaneous Electrical Nerve Stimulation (TENS) as an adjunct to standard postoperative care for pain management following cesarean delivery. Eligible women undergoing cesarean delivery under spinal anesthesia will be randomly assigned in a 1:1 ratio to either the intervention group, which will receive continuous TENS in addition to standard postoperative analgesia, or the control group, which will receive standard postoperative analgesia alone. The primary outcome is the Quality of Recovery-15 (QoR-15) score assessed 24 hours after cesarean delivery.
Eligibility criteria
Qualifiers
Women aged 18-45 years.
Undergoing CD under spinal anesthesia.
Hemodynamically stable postoperatively.
Able to provide informed consent.
Disqualifiers
Undergoing CD under epidural or general anesthesia.
Skin lesions or infection at electrode placement sites.
Pacemaker or implanted electrical devices.
Neurological disorders affecting pain perception.
Trial design
Treatments tested in this trial
- TENS
Treatment groups
196 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov